Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lilja

Showing results (131-140 of 185) with videos related to

Pageof 19
Sort By:
Clinical Chemistry|September 1, 1991
Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsinH Lilja, A Christensson, U Dahlén, et al.
Urology|May 1, 1999
Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mLM Törnblom, U Norming, J Adolfsson, et al.
The Prostate|January 1, 1990
Species- and organ-specificity of secretory proteins derived from human prostate and seminal vesiclesG Aumüller, J Seitz, H Lilja, et al.
Urology|February 11, 1998
Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serumT Björk, B Ljungberg, T Piironen, et al.
The Journal of Urology|December 22, 1999
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serumC Becker, T Piironen, K Pettersson, et al.
Urology|December 1, 1996
In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samplesT Piironen, K Pettersson, M Suonpää, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 11, 1999
The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjectsK J Obrant, S M Käkönen, J Astermark, et al.
BJU International|June 10, 2000
Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in SwedenJ Hugosson, G Aus, C Becker, et al.
Urology|October 1, 1994
Comparability of the Tandem-R and IMx assays for the measurement of serum prostate-specific antigenS J Jacobsen, H Lilja, G G Klee, et al.
Biochemical and Biophysical Research Communications|August 24, 1995
Production of recombinant PSA and HK2 and analysis of their immunologic cross-reactivityJ Lövgren, T Piironen, C Overmo, et al.
Pageof 19

Showing results (131-140 of 185) with videos related to

Sort By:
Pageof 19
Clinical Chemistry|September 1, 1991
Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsinH Lilja, A Christensson, U Dahlén, et al.
Urology|May 1, 1999
Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mLM Törnblom, U Norming, J Adolfsson, et al.
The Prostate|January 1, 1990
Species- and organ-specificity of secretory proteins derived from human prostate and seminal vesiclesG Aumüller, J Seitz, H Lilja, et al.
Urology|February 11, 1998
Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serumT Björk, B Ljungberg, T Piironen, et al.
The Journal of Urology|December 22, 1999
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serumC Becker, T Piironen, K Pettersson, et al.
Urology|December 1, 1996
In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samplesT Piironen, K Pettersson, M Suonpää, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 11, 1999
The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjectsK J Obrant, S M Käkönen, J Astermark, et al.
BJU International|June 10, 2000
Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in SwedenJ Hugosson, G Aus, C Becker, et al.
Urology|October 1, 1994
Comparability of the Tandem-R and IMx assays for the measurement of serum prostate-specific antigenS J Jacobsen, H Lilja, G G Klee, et al.
Biochemical and Biophysical Research Communications|August 24, 1995
Production of recombinant PSA and HK2 and analysis of their immunologic cross-reactivityJ Lövgren, T Piironen, C Overmo, et al.
Pageof 19